Literature DB >> 12824228

The Activities of Daily Vision Scale for cataract surgery outcomes: re-evaluating validity with Rasch analysis.

Konrad Pesudovs1, Estibaliz Garamendi, John P Keeves, David B Elliott.   

Abstract

PURPOSE: The Activities of Daily Vision Scale (ADVS) has been extensively validated by traditional methodology. In the current study, Rasch analysis was used to explore further the validity of the ADVS and to determine whether improvements could be made.
METHODS: Forty-three patients with cataract underwent visual acuity (VA) and contrast sensitivity (CS) testing and completed the ADVS. The data were Rasch analyzed and the value of response scale and item reduction explored. A shortened version and the original ADVS were tested for criterion validity by determining correlations with VA and CS.
RESULTS: The ADVS data contained abnormally distributed items and items with ceiling effects and empty response categories. Therefore, items benefited from shortening the response scale, the optimum length being three responses. There was poor targeting of item difficulty to patient ability, because many patients with cataract were sufficiently able that they had no difficulty with many activities. Items were eliminated if the task was too easy or did not fit with the overall concept of visual disability determined by the Rasch model. A reduced ADVS version was established that had adequate precision, equivalent criterion validity, and improved targeting of item difficulty to patient ability, but this version was still not ideal.
CONCLUSIONS: Despite careful traditional validation, the ADVS data contained inadequacies exposed by Rasch analysis. Through Rasch scaling, particularly with response scale reduction, the ADVS can be improved, but additional questions seem to be needed to suit the more able, including patients undergoing second eye cataract surgery. There remains a need to develop Rasch-scaled measures of visual disability for use in ophthalmic outcomes research.

Entities:  

Mesh:

Year:  2003        PMID: 12824228     DOI: 10.1167/iovs.02-1075

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  26 in total

1.  Influence of photodynamic therapy for age related macular degeneration upon subjective vision related quality of life.

Authors:  Alex W Hewitt; V Swetha Jeganathan; Juanita E Kidd; Konrad Pesudovs; Nitin Verma
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-01-13       Impact factor: 3.117

2.  Rasch analysis of the Ocular Surface Disease Index (OSDI).

Authors:  Bradley E Dougherty; Jason J Nichols; Kelly K Nichols
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-07       Impact factor: 4.799

3.  An enhanced functional ability questionnaire (faVIQ) to measure the impact of rehabilitation services on the visually impaired.

Authors:  James Stuart Wolffsohn; Jonathan Jackson; Olivia Anne Hunt; Charles Cottriall; Jennifer Lindsay; Richard Gilmour; Anne Sinclair; Robert Harper
Journal:  Int J Ophthalmol       Date:  2014-02-18       Impact factor: 1.779

4.  Assessment of the psychometric properties of the Chinese Impact of Vision Impairment questionnaire in a population-based study: findings from the Singapore Chinese Eye Study.

Authors:  Eva K Fenwick; Peng Guan Ong; Charumathi Sabanayagam; Gwyn Rees; Jing Xie; Edith Holloway; Ching-Yu Cheng; Tien Y Wong; Blanche Lim; Pok Chien Tan; Ecosse L Lamoureux
Journal:  Qual Life Res       Date:  2015-09-29       Impact factor: 4.147

5.  Development of a battery of functional tests for low vision.

Authors:  Bradley E Dougherty; Scott R Martin; Corey B Kelly; Lisa A Jones; Thomas W Raasch; Mark A Bullimore
Journal:  Optom Vis Sci       Date:  2009-08       Impact factor: 1.973

6.  Development of a vision-targeted health-related quality of life item measure.

Authors:  Sylvia H Paz; Jerry Slotkin; Roberta McKean-Cowdin; Paul Lee; Cynthia Owsley; Susan Vitale; Rohit Varma; Richard Gershon; Ron D Hays
Journal:  Qual Life Res       Date:  2013-03-09       Impact factor: 4.147

7.  Quality of life in age-related macular degeneration: a review of available vision-specific psychometric tools.

Authors:  Robert P Finger; Monika Fleckenstein; Frank G Holz; Hendrik P N Scholl
Journal:  Qual Life Res       Date:  2008-05       Impact factor: 4.147

8.  Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease.

Authors:  B A Noble; R S K Loh; S MacLennan; K Pesudovs; A Reynolds; L R Bridges; J Burr; O Stewart; S Quereshi
Journal:  Br J Ophthalmol       Date:  2004-05       Impact factor: 4.638

9.  Validation of the Glaucoma Quality of Life-15 Questionnaire in Serbian language.

Authors:  Ivan Sencanic; Tatjana Gazibara; Jelena Dotlic; Miroslav Stamenkovic; Vesna Jaksic; Marija Bozic; Anita Grgurevic
Journal:  Int J Ophthalmol       Date:  2018-10-18       Impact factor: 1.779

Review 10.  Choosing appropriate patient-reported outcomes instrument for glaucoma research: a systematic review of vision instruments.

Authors:  Jemaima Che Hamzah; Jennifer M Burr; Craig R Ramsay; Augusto Azuara-Blanco; Maria Prior
Journal:  Qual Life Res       Date:  2011-01-04       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.